194 related articles for article (PubMed ID: 18023079)
1. Quantitative mass spectrometry to investigate epidermal growth factor receptor phosphorylation dynamics.
Schuchardt S; Borlak J
Mass Spectrom Rev; 2008; 27(1):51-65. PubMed ID: 18023079
[TBL] [Abstract][Full Text] [Related]
2. Receptor tyrosine kinase signaling: a view from quantitative proteomics.
Dengjel J; Kratchmarova I; Blagoev B
Mol Biosyst; 2009 Oct; 5(10):1112-21. PubMed ID: 19756300
[TBL] [Abstract][Full Text] [Related]
3. Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins.
Gotoh N
Cancer Sci; 2008 Jul; 99(7):1319-25. PubMed ID: 18452557
[TBL] [Abstract][Full Text] [Related]
4. Mitogenic signaling pathways induced by G protein-coupled receptors.
Rozengurt E
J Cell Physiol; 2007 Dec; 213(3):589-602. PubMed ID: 17786953
[TBL] [Abstract][Full Text] [Related]
5. S-Nitrosylation of the epidermal growth factor receptor: a regulatory mechanism of receptor tyrosine kinase activity.
Murillo-Carretero M; Torroglosa A; Castro C; Villalobo A; Estrada C
Free Radic Biol Med; 2009 Feb; 46(4):471-9. PubMed ID: 19056486
[TBL] [Abstract][Full Text] [Related]
6. Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission.
Gschwind A; Zwick E; Prenzel N; Leserer M; Ullrich A
Oncogene; 2001 Mar; 20(13):1594-600. PubMed ID: 11313906
[TBL] [Abstract][Full Text] [Related]
7. Betagamma subunits of G(i/o) suppress EGF-induced ERK5 phosphorylation, whereas ERK1/2 phosphorylation is enhanced.
Obara Y; Okano Y; Ono S; Yamauchi A; Hoshino T; Kurose H; Nakahata N
Cell Signal; 2008 Jul; 20(7):1275-83. PubMed ID: 18407464
[TBL] [Abstract][Full Text] [Related]
8. Vesicular trafficking of tyrosine kinase receptors and associated proteins in the regulation of signaling and vascular function.
Mukherjee S; Tessema M; Wandinger-Ness A
Circ Res; 2006 Mar; 98(6):743-56. PubMed ID: 16574915
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH
J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257
[TBL] [Abstract][Full Text] [Related]
10. Monitoring interactions between receptor tyrosine kinases and their downstream effector proteins in living cells using bioluminescence resonance energy transfer.
Tan PK; Wang J; Littler PL; Wong KK; Sweetnam TA; Keefe W; Nash NR; Reding EC; Piu F; Brann MR; Schiffer HH
Mol Pharmacol; 2007 Dec; 72(6):1440-6. PubMed ID: 17715395
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor promotes epidermal growth factor receptor nuclear accumulation by a pathway dependent on cytoskeleton integrity in human breast cancer cells.
Cortes-Reynosa P; Robledo T; Salazar EP
Arch Med Res; 2009 Jul; 40(5):331-8. PubMed ID: 19766894
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of multisite EGF receptor phosphorylation using mass spectrometry and a novel normalization approach.
Boeri Erba E; Matthiesen R; Bunkenborg J; Schulze WX; Di Stefano P; Cabodi S; Tarone G; Defilippi P; Jensen ON
J Proteome Res; 2007 Jul; 6(7):2768-85. PubMed ID: 17523611
[TBL] [Abstract][Full Text] [Related]
13. Receptor tyrosine kinases regulate alpha1D-adrenoceptor signaling properties: phosphorylation and desensitization.
Rodríguez-Pérez CE; Calvo-Ochoa E; Kalashnikova EV; Reyes-Cruz G; Romero-Avila MT; García-Sáinz JA
Int J Biochem Cell Biol; 2009 Jun; 41(6):1276-83. PubMed ID: 19038360
[TBL] [Abstract][Full Text] [Related]
14. Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands.
Higashiyama S; Iwabuki H; Morimoto C; Hieda M; Inoue H; Matsushita N
Cancer Sci; 2008 Feb; 99(2):214-20. PubMed ID: 18271917
[TBL] [Abstract][Full Text] [Related]
15. Roles for deregulated receptor tyrosine kinases and their downstream signaling molecules in hematologic malignancies.
Matsumura I; Mizuki M; Kanakura Y
Cancer Sci; 2008 Mar; 99(3):479-85. PubMed ID: 18177485
[TBL] [Abstract][Full Text] [Related]
16. Ligand discrimination by ErbB receptors: differential signaling through differential phosphorylation site usage.
Sweeney C; Carraway KL
Oncogene; 2000 Nov; 19(49):5568-73. PubMed ID: 11114736
[TBL] [Abstract][Full Text] [Related]
17. Development of multitargeted inhibitors of both the insulin-like growth factor receptor (IGF-IR) and members of the epidermal growth factor family of receptor tyrosine kinases.
Hubbard RD; Bamaung NY; Fidanze SD; Erickson SA; Palazzo F; Wilsbacher JL; Zhang Q; Tucker LA; Hu X; Kovar P; Osterling DJ; Johnson EF; Bouska J; Wang J; Davidsen SK; Bell RL; Sheppard GS
Bioorg Med Chem Lett; 2009 Mar; 19(6):1718-21. PubMed ID: 19217287
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor lacking C-terminal autophosphorylation sites retains signal transduction and high sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor.
Maegawa M; Arao T; Yokote H; Matsumoto K; Kudo K; Tanaka K; Kaneda H; Fujita Y; Ito F; Nishio K
Cancer Sci; 2009 Mar; 100(3):552-7. PubMed ID: 19154417
[TBL] [Abstract][Full Text] [Related]
19. TOB1 is regulated by EGF-dependent HER2 and EGFR signaling, is highly phosphorylated, and indicates poor prognosis in node-negative breast cancer.
Helms MW; Kemming D; Contag CH; Pospisil H; Bartkowiak K; Wang A; Chang SY; Buerger H; Brandt BH
Cancer Res; 2009 Jun; 69(12):5049-56. PubMed ID: 19491269
[TBL] [Abstract][Full Text] [Related]
20. Activation of epidermal growth factor receptor by metal-ligand complexes decreases levels of extracellular amyloid beta peptide.
Price KA; Filiz G; Caragounis A; Du T; Laughton KM; Masters CL; Sharples RA; Hill AF; Li QX; Donnelly PS; Barnham KJ; Crouch PJ; White AR
Int J Biochem Cell Biol; 2008; 40(9):1901-17. PubMed ID: 18346929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
